retatrutide side effects trial results New Phase 3 data just dropped π Eli Lilly's reported average weight loss approaching 30%, with some patients achieving historically associated with bariatric surgery. A few important caveats Retatrutide Side Effects: What Patients
Description
Who Should Not Use GLP-1 Medications According to standard clinical guidelines and prescribing information, GLP-1 medications may not be appropriate for individuals who: Have a personal or family history of medullary thyroid carcinoma Have multiple endocrine neoplasia syndrome type 2 Have a history of pancreatitis Have severe gastrointestinal disease (gastroparesis, inflammatory bowel disease) Are pregnant, planning to become pregnant, or breastfeeding Have a history of severe allergic reactions to semaglutide, tirzepatide, or any inactive ingredients This is not a replacement for prescribed medical treatment for any health condition

Speak to your GP if you experience persistent changes in sexual desire, new erectile dysfunction, or severe medication side effects
These responses are normal and understandable, but they can undermine commitment to continued treatment and lifestyle modifications
I think that potential is there for positive impact, but there are not enough studies yet. Novo Nordisk, which makes Wegovy, doesnt encourage off-label use of its obesity medications

Take out the needle and dispose of it (safely)
